Gemcitabine Hydrochloride API
| Name of Product | Gemcitabine Hydrochloride API |
|---|---|
| CAS No | 122111‑03‑9 |
| Therapeutic use:- | Antineoplastic nucleoside analog (pyrimidine antimetabolite) used against breast, lung, pancreatic cancers |
| Grade | IP/USP/EP/BP |
| Form:- | API Powder |
| Status | Commercial |
Product Overview
Gemcitabine Hydrochloride is a man-made drug that is utilized as an API.
It falls under the category of drugs called nucleoside analogs.
The drug works by inhibiting DNA from duplicating itself.
When It inhibits DNA synthesis, preventing cancer cell proliferation, the cancer cells are not able to grow.
This makes the drug effective against multiple solid tumors.
Supplied as bulk API for formulation manufacturing. It comes in a white or off-white powder form.
It is soluble in water. Complies with USP and EP pharmacopeia standards.
This ensures quality based on international regulations.
Therapeutic Applications
Gemcitabine Hydrochloride (122111-03-9) has its main usage in oncology.
It is highly valued due to its broad spectrum of activity and use as a single-agent, as well as combined, cancer therapy.
Its therapeutic uses are:
Specification Parameters
These parameters ensure the product is suitable for use in regulated pharmaceutical markets. Typical quality specifications for Gemcitabine Hydrochloride API include:
Packaging & Storage
For stability, the product should be stored at 2–8°C, protected from heat and moisture.
It should always remain sealed until use. Shelf life is typically 24 to 36 months under recommended storage conditions.
Gemcitabine Hydrochloride is packaged in:
Why Choose Us
At Actiza Pharmaceutical Pvt Ltd, we specialize in providing high-quality oncology APIs like Gemcitabine Hydrochloride (122111-03-9).
Partnering with us ensures access to reliable oncology APIs backed by quality assurance and competitive pricing.
Buyers choose us because: